Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.68792 | 29 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.6241 | 27 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.66664 | 29 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.20269 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.61199 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.59833 | 23 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.64918 | 26 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.52883 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.67653 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.08797 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5069 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.32692 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.59742 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.65531 | 29 |